The Mitochondrial Blueprint of Skin Aging: From Damage Signals to Dermatologic Interventions.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analytic synthesis
PubMed 41824483 · doi:10.14336/AD.2025.1585
What was done
This narrative review synthesized current literature on the role of mitochondrial dysfunction in skin aging and wound healing. The authors examined molecular pathways—including mitochondrial DNA damage, oxidative stress, altered mitophagy, and NAD⁺ decline—and reviewed emerging therapeutic strategies such as mitochondria-targeted antioxidants, NAD⁺ boosters, photobiomodulation, and engineered extracellular vesicles.
What was found
The abstract provides a qualitative narrative synthesis and reports no quantitative effect estimates, sample sizes, or statistical metrics. It describes how cumulative ultraviolet exposure and aging drive mitochondrial DNA mutations, excessive reactive oxygen species production, and sirtuin dysregulation, leading to fibroblast senescence and extracellular matrix degradation. It also reports that preclinical and early translational studies show improved collagen synthesis, re-epithelialization, and cellular bioenergetics following mitochondria-targeted interventions.
Why it matters
It provides an integrated conceptual framework linking cellular bioenergetics directly to cutaneous aging phenotypes and wound repair. It highlights novel translational targets for dermatology, though robust human trial data are still emerging.
Limits
The paper is a narrative review with no systematic search methodology, meta-analytic data, or reported quantitative outcomes in the abstract. Much of the evidence relies on preclinical models or early translational studies, meaning clinical efficacy, optimal dosing, and long-term safety in human populations remain unproven.
Cited by
- supports Skin fibroblasts and keratinocytes accumulate mitochondrial damage with aging.